DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,312,042 | -30.1% | 693,749 | 0.0% | 9.30% | -26.5% |
| Q2 2023 | $20,472,533 | -65.4% | 693,749 | -73.0% | 12.64% | -55.7% |
| Q1 2023 | $59,183,977 | -42.0% | 2,568,749 | -30.0% | 28.57% | +9.3% |
| Q4 2022 | $102,027,910 | -9.4% | 3,668,749 | 0.0% | 26.13% | +79.0% |
| Q3 2022 | $112,594,000 | -26.0% | 3,668,749 | -29.0% | 14.60% | -21.3% |
| Q2 2022 | $152,116,000 | – | 5,168,749 | – | 18.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |